Long-term monitoring during clofibrate therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D001774:Blood Chemical Analysis; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D001835:Body Weight; D002648:Child; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004798:Enzymes / Q000097:blood; D005951:Glucose Tolerance Test; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008875:Middle Aged; D011422:Propionates / Q000627:therapeutic use*; D011674:Pulse; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014556:Urine / Q000032:analysis
D000924:Anticholesteremic Agents; D001786:Blood Glucose; D004798:Enzymes; D008074:Lipoproteins; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate